Compendium of Notified Ceiling Prices NLEM 2015

Size: px
Start display at page:

Download "Compendium of Notified Ceiling Prices NLEM 2015"

Transcription

1 Compendium of Notified Ceiling Prices NLEM 2015 The Compendium of Notified Ceiling Prices of Scheduled Drugs as per NLEM 2015 has been brought out with the objective of disseminating information related to notified ceiling prices in respect of scheduled drugs, to all stakeholders, particularly Manufacturers, including importers and marketers of pharmaceuticals products, end consumers and consumer welfare organisations / NGOs; stockists/ distributors, dealers and retailers; Public health experts and enforcement functionaries. The compendium has consolidated all the information relating to ceiling prices of essential medicines fixed by NPPA, Therapeutic group wise which will be Useful and informative to all stakeholders. We hope that all stakeholders will find this compendium extremely useful as a ready reckoner for price compliance under DPCO Although every effort has been made to maintain accuracy in the compendium, We shall not be responsible for any error or mistake that may have inadvertently crept into the compendium. The stakeholders are, therefore, advised to refer to the relevant official Gazette notification before taking any action on the basis of this compendium which may be accessed from the website at or The Compendium of Notified Ceiling Prices of Scheduled Drugs as per NLEM 2011 has been brought out separately.

2 Sr. No. Unique No. as per NLEM Medicines Level of Healthcare Dosage form as included in Schedule-I Dosage form, other than the dosage form included in Schedule-I, but in same strength and route of administration NLEM 2011 Status Unit Ceiling Price Notification No. Notification Date Remarks Dosage form Strengths Dosage form Strengths Section 1-Anesthetic agents 1.1-General Anesthetics and oxygen Halothane S,T Inhalation - YES 1 ML 6.30 S.O. 644(E) w.e.f Isoflurane S,T Inhalation - YES 1 ML S.O. 644(E) w.e.f Ketamine P,S,T Injection 10 mg/ml YES 1 ml 9.83 S.O.3181(E) ML S.O. 644(E) w.e.f Injection 50 mg/ml YES 1 ml 9.69 S.O.3181(E) ML S.O. 644(E) w.e.f Nitrous oxide P,S,T Inhalation - YES Cubic Meter S.O. 644(E) w.e.f Oxygen P,S,T Inhalation (Medicinal gas) - YES Cubic Meter S.O. 644(E) w.e.f Propofol P,S,T Injection 10 mg/ml YES 1 ml 6.7 S.O.3181(E) ml 9.28 S.O. 644(E) w.e.f Sevoflurane T Inhalation - YES 1 ML S.O. 644(E) w.e.f Thiopentone P,S,T Powder for Injection 0.5 g YES Powder for Injection 1 g YES 1.2-Local anesthetics Each Pack S.O. 644(E) w.e.f Each Pack S.O.3181(E) Gram S.O. 644(E) w.e.f Bupivacaine S,T Injection 0.25% YES 1 ml 2.27 S.O.3181(E) ML 2.48 S.O. 644(E) w.e.f Injection 0.50% YES 1 ml 3.64 S.O.3181(E) ML 3.75 S.O. 644(E) w.e.f Injection 0.5% with 7.5% glucose YES 1 ML 6.15 S.O. 644(E) w.e.f Lignocaine P,S,T Topical forms 2-5% YES 1 ML/ Gram 1.26 S.O. 644(E) w.e.f Injection 1% YES Each Pack 7.36 S.O.3181(E) Each Pack 7.37 S.O. 644(E) w.e.f Injection 2% YES 1 ML 0.91 S.O.3181(E) ML 1.07 S.O. 644(E) w.e.f Injection 5% with 7.5% Glucose YES 1 ML 4.22 S.O. 644(E) w.e.f Lignocaine (A) + Adrenaline (B) P,S,T Injection 1% (A) + 1 : (5mcg/ml) (B) YES Each Pack 0.73 S.O. 644(E) w.e.f Injection 2% (A) + 1 : (5mcg/ml) (B) YES 1 ML 0.99 S.O. 644(E) w.e.f Prilocaine (A) + Lignocaine (B) T Cream 2.5% (A) + 2.5% (B) 1 Gram S.O. 1687(E) Immediate 1.3-Preoperative medication and sedation for short term procedures Atropine P,S,T Injection 0.6 mg/ml YES 1 ML 3.73 S.O. 2730(E) ML 4.30 S.O. 644(E) w.e.f Glycopyrrolate S,T Injection 0.2 mg/ml 1 ml S.O. 1405(E) Immediate Midazolam P,S,T Tablet 7.5 mg Tablet 15 mg Oral liquid 2 mg/ml Injection 1 mg/ml YES 1 ML 6.23 S.O. 644(E) w.e.f Injection 5 mg/ml YES 1 ML S.O. 644(E) w.e.f Morphine P,S,T Injection 10 mg/ml YES 1 ML S.O. 644(E) w.e.f Injection 15 mg/ml Section 2- Analgesics, antipyretics, non steroidal anti inflammatory medicines, medicines used to treat gout and disease modifying agents used in rheumatoid disorders 2.1- Non-opioid analgesics, antipyretics and no steroidal anti -inflammatory medicines Acetylsalicylic acid P,S,T Tablet 300 mg to 500 mg 300 mg YES 325 mg YES 1 Tablet 0.21 S.O. 644(E) w.e.f Tablet 0.73 S.O. 644(E) w.e.f

3 350 mg YES Effervescent/ Dispersible/ Enteric coated Tablet 300 mg to 500 mg Diclofenac P,S,T Tablet 50 mg YES 1 Tablet 1.77 S.O. 1351(E) Tablet 2.09 S.O. 644(E) w.e.f Injection 25 mg/ml YES 1 ML 1.60 S.O. 644(E) w.e.f Ibuprofen P,S,T Tablet 200 mg YES 1 Tablet 0.35 S.O. 2730(E) Tablet 0.44 S.O. 644(E) w.e.f Tablet 400 mg YES 1 Tablet 0.65 S.O. 2730(E) Tablet 0.72 S.O. 644(E) w.e.f Oral liquid 100 mg/5 ml YES 1 ML 0.22 S.O. 644(E) w.e.f Mefenamic acid P,S,T Capsule 250 mg Capsule 500 mg Oral liquid 100 mg/5 ml 1 ml 0.48 S.O. 1561(E) Immediate Paracetamol P,S,T Tablet 500 mg YES 1 Tablet 0.83 S.O. 1351(E) Tablet 1.01 S.O. 644(E) w.e.f Tablet 650 mg 1 Tablet 1.71 S.O. 1253(E) w.e.f Tablet 1.76 S.O. 1253(E) Immediate All licenced oral liquid dosage forms All licenced oral liquid dosage strengths 100 mg /5 ml 1 ml 0.47 S.O. 2962(E) mg /5 ml 1 ml 0.54 S.O. 2962(E) mg /5 ml 1 ml 0.56 S.O. 2962(E) mg /5 ml 1 ml 0.59 S.O. 2962(E) mg /5 ml 1 ml 0.48 S.O. 2962(E) Injection 150 mg/ml YES 1 ML 3.69 S.O. 644(E) w.e.f Suppository 80 mg YES 1 Suppository 7.47 S.O. 644(E) w.e.f Suppository 170 mg YES 1 Suppository 8.67 S.O. 644(E) w.e.f Opioid analgesics Fentanyl S,T Injection 50 mcg/ml YES 1 ML S.O. 644(E) w.e.f Morphine P,S,T Tablet 10 mg YES 1 Tablet 5.42 S.O. 644(E) w.e.f Injection 10 mg/ml YES 1 ML S.O. 644(E) w.e.f Injection 15 mg/ml Tramadol S,T Capsule 50 mg YES 1 Capsule 4.20 S.O.2195(E) Capsule 6.48 S.O. 644(E) w.e.f Capsule 100 mg YES Tramadol Tablet Tramadol-100mg 1 Tablet S.O. 1687(E) Immediate Injection 50 mg/ml YES 1 ML 12.6 S.O. 644(E) w.e.f Medicines used to treat gout Allopurinol P,S,T Tablet 100 mg YES 1 Tablet 1.76 S.O. 1351(E) Tablet 2.25 S.O. 644(E) w.e.f Tablet 300 mg 1 Tablet 6.94 S.O. 1253(E) w.e.f Tablet 7.13 S.O. 1253(E) Immediate Colchicine P,S,T Tablet 0.5 mg YES 1 Tablet 2.88 S.O.2569(E) Tablet 3.09 S.O. 644(E) w.e.f Disease modifying agents used in rheumatoid disorders Azathioprine S,T Tablet 50 mg YES 1 Tablet 9.02 S.O. 1351(E) Tablet S.O. 644(E) w.e.f Hydroxychloroquine S,T Tablet 200 mg YES 1 Tablet 5.50 S.O. 1819(E) Immediate 1 Tablet 6.06 S.O. 644(E) w.e.f Tablet 400 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Leflunomide S,T Tablet 10 mg YES 1 Tablet 9.30 S.O.2195(E) Tablet S.O. 644(E) w.e.f Tablet 20 mg YES 1 Tablet S.O.2195(E) Tablet S.O. 644(E) w.e.f Methotrexate S,T Tablet 5 mg YES 1 Tablet 7.45 S.O. 2963(E) Tablet 8.16 S.O. 644(E) w.e.f Tablet 7.5 mg YES 1 Tablet S.O.2195(E) Tablet 12.1 S.O. 644(E) w.e.f Tablet 10 mg YES 1 Tablet S.O.2195(E) Tablet S.O. 644(E) w.e.f Injection 25 mg/ ml 1 ml 42.8 S.O. 1405(E) Immediate 2

4 2.4.5 Sulfasalazine S,T Tablet 500 mg YES 1 Tablet 3.70 S.O. 1819(E) Immediate 1 Tablet 3.92 S.O. 644(E) w.e.f Section 3-Antiallergics and medicines used in anaphylaxis 3.1 Adrenaline P,S,T Injection 1 mg/ml YES 1 ml S.O.3181(E) ML S.O. 644(E) w.e.f Cetirizine P,S,T Tablet 10 mg YES 1 Tablet 1.53 S.O. 1351(E) Tablet 1.94 S.O. 644(E) w.e.f Oral liquid 5 mg/5ml YES 1 ml 0.55 S.O. 1687(E) Immediate 0.57 S.O. 644(E) w.e.f Chlorpheniramine P,S,T Tablet 4 mg YES 1 Tablet S.O.2569(E) Tablet S.O. 644(E) w.e.f Oral liquid 2 mg/5 ml 3.4 Dexamethasone P,S,T Tablet 0.5 mg YES 1 Tablet 0.18 S.O. 1819(E) Immediate 1 Tablet 0.20 S.O. 644(E) w.e.f Injection 4 mg/ml YES 1 ml 2.69 S.O. 644(E) w.e.f Hydrocortisone P,S,T Powder for Injection 100 mg YES EACH PACK S.O. 1687(E) Immediate Each Pack S.O. 644(E) w.e.f Pheniramine P,S,T Injection mg/ml YES 1 ml 1.41 S.O. 644(E) w.e.f Prednisolone P,S,T Tablet 5 mg YES 1 Tablet 0.52 S.O. 1819(E) Immediate 1 Tablet 0.58 S.O. 644(E) w.e.f Tablet 10 mg YES 1 Tablet 0.90 S.O. 1819(E) Immediate 1 Tablet 0.99 S.O. 644(E) w.e.f Tablet 20 mg YES 1 Tablet 1.81 S.O.2195(E) Tablet 1.85 S.O. 644(E) w.e.f Oral liquid 5 mg/5ml 1 ml 0.40 S.O. 1561(E) Immediate Oral liquid 15 mg/5 ml 1 ml 0.71 S.O. 1561(E) Immediate Section 4-Antidotes and other substances used in poisoning 4.1- Nonspecific Activated charcoal P,S,T Powder (as licensed) YES 4.2-Specific Atropine P,S,T Injection 1 mg/ml YES Calcium gluconate P,S,T Injection 100 mg/ml YES 10 ml Ampoule S.O. 644(E) w.e.f Desferrioxamine S,T Powder for Injection 500 mg YES Each Pack S.O. 644(E) w.e.f Dimercaprol S,T Injection 50 mg/ml YES Methylthioninium chloride (Methylene blue) S,T Injection 10 mg/ml N-acetylcysteine P,S,T Sachet 200 mg Injection 200 mg/ml YES 1 ml S.O. 644(E) w.e.f Naloxone P,S,T m Injection 0.4 mg/ml YES 1 ml S.O. 644(E) w.e.f Neostigmine P,S,T Injection 0.5 mg/ml YES 1 ml 4.04 S.O. 2730(E) ml 4.35 S.O. 644(E) w.e.f Penicillamine S,T Capsule 250 mg YES 1 Capsule S.O. 1686(E) Immediate 1 Capsule 14.1 S.O. 644(E) w.e.f Pralidoxime chloride (2- PAM) P,S,T Injection 25 mg/ml YES Snake venom antiserum a) Soluble/ liquid polyvalent P,S,T Injection - YES 1 ml S.O. 644(E) w.e.f b) Lyophilized polyvalent Powder for Injection - YES 1 ml S.O. 644(E) w.e.f Sodium nitrite S,T Injection 30 mg/ml YES 1 ml S.O. 644(E) w.e.f Sodium thiosulphate S,T Injection 100 mg/ml Section 5-Anticonvulsants/Antiepileptics 5.1 Carbamazepine P,S,T Tablet 100 mg YES 1 Tablet 0.64 S.O. 2963(E) Tablet 0.75 S.O. 644(E) w.e.f Tablet 200 mg YES 1 Tablet 1.28 S.O.2195(E) Tablet 1.48 S.O. 644(E) w.e.f CR Tablet 200 mg 1 Tablet 1.44 S.O. 1253(E) w.e.f Tablet 1.48 S.O. 1253(E) Immediate Tablet 400 mg 1 Tablet 3.07 S.O. 1253(E) w.e.f Tablet 3.16 S.O. 1253(E) Immediate CR Tablet 400 mg 1 Tablet 2.83 S.O. 1253(E) w.e.f YES 3

5 1 Tablet 2.91 S.O. 1253(E) Immediate Oral liquid 100 mg/5 ml YES 1 ml 0.18 S.O. 2730(E) ml 0.21 S.O. 644(E) w.e.f Oral liquid 200 mg/5 ml 5.2 Clobazam S,T Tablet 5 mg 1 Tablet 4.77 S.O. 1253(E) w.e.f Tablet 4.90 S.O. 1253(E) Immediate Tablet 10 mg 1 Tablet 8.38 S.O. 1253(E) w.e.f Tablet 8.61 S.O. 1253(E) Immediate 5.3 Diazepam P,S,T Oral liquid 2 mg/5 ml YES Injection 5 mg/ml YES 1 ml 5.62 S.O.3181(E) ml 6 S.O. 644(E) w.e.f Suppository 5 mg YES 1 Suppository 5.54 S.O. 2730(E) Suppository 5.54 S.O. 644(E) w.e.f Levetiracetam S,T Tablet 250 mg 1 Tablet 5.43 S.O. 1253(E) w.e.f Tablet 5.58 S.O. 1253(E) Immediate Tablet 500 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Tablet 750 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate ER Tablet 750 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Oral liquid 100 mg/ml 1 ml 3.38 S.O. 2964(E) ml 3.53 S.O. 1561(E) Immediate Injection 100 mg/ml 1 ml S.O. 1687(E) Immediate 5.5 Lorazepam P,S,T Tablet 1 mg 1 Tablet 1.92 S.O. 1253(E) w.e.f Tablet 1.97 S.O. 1253(E) Immediate Tablet 2 mg 1 Tablet 2.33 S.O. 1253(E) w.e.f Tablet 2.39 S.O. 1253(E) Immediate Injection 2 mg/ml YES 1 ml 7.94 S.O. 644(E) w.e.f Magnesium sulphate S,T Injection 500 mg/ml YES 1 ml 5.32 S.O. 644(E) w.e.f Phenobarbitone P,S,T Tablet 30 mg YES 1 Tablet 1.12 S.O.2195(E) Tablet 1.59 S.O. 644(E) w.e.f Tablet 60 mg YES 1 Tablet 1.64 S.O. 1351(E) Tablet 2.56 S.O. 644(E) w.e.f Oral liquid 20 mg/5 ml YES 1 ml 0.54 S.O. 644(E) w.e.f S,T Injection 200 mg/ml YES 1 ml S.O. 2730(E) ml S.O. 644(E) w.e.f Phenytoin P,S,T Tablet 50 mg YES 1 Tablet 0.7 S.O. 1686(E) Immediate 1 Tablet 0.83 S.O. 644(E) w.e.f Tablet 100 mg YES 1 Tablet 1.27 S.O. 1819(E) Immediate 1 Tablet 1.53 S.O. 644(E) w.e.f Tablet 300 mg 1 Tablet 4.39 S.O. 1253(E) w.e.f Tablet 4.51 S.O. 1253(E) Immediate ER Tablet 300 mg 1 Tablet 5.39 S.O. 1253(E) w.e.f Tablet 5.54 S.O. 1253(E) Immediate Oral liquid 30 mg/5 ml Oral liquid 125 mg/5 ml Injection 25 mg/ml YES 1 ml 2.33 S.O. 644(E) w.e.f Injection 50 mg/ml YES 1 ml 4.98 S.O.3181(E) ml 5.54 S.O. 644(E) w.e.f Sodium valproate P,S,T Tablet 200 mg YES 1 Tablet 2.75 S.O.2195(E) Tablet 3.3 S.O. 644(E) w.e.f Tablet 300 mg 1 Tablet 3.69 S.O. 1253(E) w.e.f Tablet 3.79 S.O. 1253(E) Immediate CR Tablet 300 mg Tablet 500 mg YES 1 Tablet 6.43 S.O.2195(E) Tablet 7.71 S.O. 644(E) w.e.f CR Tablet 500 mg Oral liquid 200 mg/5ml YES 1 ml 0.62 S.O. 644(E) w.e.f T Injection 100 mg/ml YES 1 ml 5.79 S.O. 644(E) w.e.f Section 6-Anti infective medicines 6.1-Anthelminthics Intestinal anthelminthics Albendazole P,S,T Tablet 400 mg YES 1 Tablet 7.15 S.O.2195(E) Tablet S.O. 644(E) w.e.f Oral liquid 200 mg/5 ml YES 1 ml 1.59 S.O. 644(E) w.e.f

6 Mebendazole P,S,T Tablet 100 mg 1 Tablet 2.72 S.O. 1253(E) w.e.f Tablet 2.80 S.O. 1253(E) Immediate Oral liquid 100 mg/5 ml 1 ml 0.73 S.O. 1561(E) Immediate Antifilarial Diethy lcarbamazine P,S,T Tablet 50 mg YES 1 Tablet 0.50 S.O.2195(E) Tablet 0.51 S.O. 644(E) w.e.f Tablet 100 mg 1 Tablet 1.26 S.O. 1253(E) w.e.f Tablet 1.30 S.O. 1253(E) Immediate Oral liquid 120 mg/5 ml 1 ml 0.43 S.O. 1561(E) Immediate Anti-schistosomal & anti-trematodal medicine Praziquantel S,T Tablet 600 mg YES 1 Tablet S.O. 644(E) w.e.f Antibacterials Beta lactam medicines Amoxicillin P,S,T Capsule 250 mg YES 1 Capsule 2.05 S.O. 1351(E) Capsule 2.96 S.O. 644(E) w.e.f Capsule 500 mg YES 1 Capsule 5.70 S.O. 1819(E) Immediate 1 Capsule 6.54 S.O. 644(E) w.e.f Oral liquid 250 mg/5 ml 1 ml 1.26 S.O. 1561(E) Immediate Amoxicillin (A) + Clavulanic acid (B) P,S,T Tablet 500 mg (A) mg (B) YES 1 Tablet Immediate 1 Tablet S.O. 644(E) w.e.f Oral liquid 200 mg (A) mg(b)/5 ml YES 1 ml 1.68 S.O. 1351(E) ml 2.01 S.O. 644(E) w.e.f Dry Syrup 125 mg (A) (B)/5 ml 1 ml 2.00 S.O. 1561(E) Immediate S,T Powder for Injection 500 mg (A) mg (B) YES EACH PACK S.O. 644(E) w.e.f Powder for Injection 1 g (A) mg (B) YES EACH PACK S.O. 1819(E) Immediate EACH PACK S.O. 644(E) w.e.f Ampicillin P,S,T Powder for Injection 500 mg YES EACH PACK 14.4 S.O. 644(E) w.e.f Powder for Injection 1 g EACH PACK S.O. 1405(E) Immediate Benzathine benzylpenicillin P,S,T Powder for Injection 6 lac units YES 1 Injection 8.17 S.O. 644(E) w.e.f Powder for Injection 12 lac units YES 1 Injection S.O. 644(E) w.e.f Benzyl penicillin P,S,T Powder for Injection 10 lac units Cefadroxil P,S,T Tablet 500 mg 1 Tablet 3.75 S.O. 1253(E) w.e.f Tablet 3.85 S.O. 1253(E) Immediate Cefadroxil Capsule Cefadroxil -500mg 1 Capsule 6.64 S.O. 1687(E) Immediate Tablet 1 g 1 Tablet 5.83 S.O. 2962(E) Oral liquid 125 mg/5 ml 1 ml 0.58 S.O. 1561(E) Immediate Cefazolin P,S,T Powder for Injection 500 mg EACH PACK S.O. 2962(E) Powder for Injection 1 g EACH PACK S.O. 1405(E) Immediate Cefixime S,T Tablet 200 mg YES 1 Tablet 8.48 S.O. 1819(E) Immediate 1 Tablet S.O. 644(E) w.e.f Tablet 400 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Oral liquid 50 mg/5 ml 1 ml 1.34 S.O. 1687(E) Immediate Oral liquid 100 mg/5 ml 1 ml 1.99 S.O. 1687(E) Immediate Cefotaxime S,T Powder for Injection 250 mg YES EACH PACK S.O. 644(E) w.e.f Powder for Injection 500 mg YES EACH PACK S.O. 644(E) w.e.f Powder for Injection 1 g EACH PACK S.O. 1405(E) Immediate EACH PACK S.O. 1817(E) Ceftazidime S,T Powder for Injection 250 mg YES EACH PACK 68.1 S.O. 644(E) w.e.f Powder for Injection 1 g YES EACH PACK S.O. 644(E) w.e.f Ceftriaxone S,T Powder for Injection 250 mg YES EACH PACK 22.9 S.O. 1351(E) EACH PACK S.O. 644(E) w.e.f Powder for Injection 500 mg EACH PACK S.O. 1405(E) Immediate Powder for Injection 1 g YES EACH PACK S.O. 1686(E) Immediate EACH PACK S.O. 644(E) w.e.f Powder for Injection 2 g EACH PACK S.O. 1405(E) Immediate Cloxacillin P,S,T Capsule 250 mg YES 1 Capsule 1.3 S.O. 644(E) w.e.f Capsule 500 mg YES 1 Capsule 2.24 S.O. 644(E) w.e.f Oral liquid 125 mg/5 ml YES Powder for Injection 250 mg YES EACH PACK 5.59 S.O. 644(E) w.e.f Piperacillin (A) + Tazobactam (B) T Powder for Injection 1 g (A) mg (B) EACH PACK S.O. 1405(E) Immediate 5

7 Powder for Injection 2 g (A) mg (B) EACH PACK S.O. 1405(E) Immediate Powder for Injection 4 g (A) mg (B) EACH PACK S.O. 1405(E) Immediate Other antibacterials Azithromycin P,S,T Tablet 250 mg YES 1 Tablet 9.06 S.O. 1686(E) Immediate 1 Tablet S.O. 644(E) w.e.f Azithromycin Capsules Azithromycin mg 1 Capsule 9.75 S.O.3180 (E) Tablet 500 mg YES 1 Tablet S.O. 1686(E) Immediate 1 Tablet S.O. 644(E) w.e.f Azithromycin Capsules Azithromycin- 500 mg 1 Capsule S.O.3180 (E) Oral liquid 200 mg/5 ml 1 ml 2.85 S.O. 1687(E) Immediate Powder for Injection 500 mg YES EACH PACK S.O. 644(E) w.e.f Ciprofioxacin P,S,T Tablet 250 mg YES 1 Tablet 1.62 S.O. 1686(E) Immediate 1 Tablet 2.27 S.O. 644(E) w.e.f Tablet 2.33 S.O. 1882(E) Tablet 500 mg YES 1 Tablet 3.30 S.O. 1686(E) Immediate 1 Tablet 3.90 S.O. 644(E) w.e.f Oral liquid 250 mg/5 ml Injection 200 mg/100ml YES 1 ml S.O. 644(E) w.e.f Clarithromycin S,T Tablet 250 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Tablet 500 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Oral liquid 125 mg/5 ml 1 ml 4.01 S.O. 1561(E) Immediate Co-trimoxazole [Sulphamethoxazole (A) + Trimethoprim (B)] P,S,T Tablet 400 mg (A) + 80 mg (B) YES 1 Tablet 0.62 S.O. 644(E) w.e.f Tablet 800 mg (A) mg (B) YES 1 Tablet 1.33 S.O. 644(E) w.e.f Oral liquid 200 mg (A) + 40 mg (B)/5 ml YES 1 ml 0.28 S.O. 644(E) w.e.f Doxycycline P,S,T Capsule 100 mg 1 Capsule 2.32 S.O.2568(E) Doxycycline Tablet Doxycycline mg 1 Tablet 0.9 S.O.3181(E) Dry Syrup 50 mg/5 ml Gentamicin P,S,T Injection 10 mg/ml 1 ml 3.21 S.O. 644(E) w.e.f Injection 40 mg/ml YES 1 ml 2.34 S.O. 644(E) w.e.f Metronidazole P,S,T Tablet 200 mg YES 1 Tablet 0.40 S.O.2195(E) Tablet 0.45 S.O. 644(E) w.e.f Tablet 400 mg YES 1 Tablet 0.75 S.O. 1819(E) Immediate 1 Tablet 0.81 S.O. 644(E) w.e.f Tablet 0.83 S.O. 3023(E) Oral liquid 200 mg/5 ml 1 ml 0.27 S.O.3182 (E) ml 0.25 S.O. 1561(E) Immediate Injection 500 mg/100 ml YES 1 ml S.O. 644(E) w.e.f Nitrofurantoin P,S,T Tablet 100 mg YES 1 Tablet 6.71 S.O. 2730(E) Tablet 7.38 S.O. 644(E) w.e.f Nitrofurantoin Capsules Nitrofurantoin mg 1 Capsule 6.51 S.O.3180 (E) Oral liquid 25 mg/5 ml 1 ml 0.76 S.O. 1561(E) Immediate Vancomycin T Powder for Injection 250 mg Powder for Injection 500 mg YES EACH PACK S.O. 644(E) w.e.f Powder for Injection 1 g YES EACH PACK S.O. 644(E) w.e.f Antileprosy medicines Clofazimine P,S,T Capsule 50 mg YES 1 Capsule 1.28 S.O.2569(E) Capsule 1.37 S.O. 644(E) w.e.f Capsule 100 mg YES 1 Capsule 2.20 S.O.2569(E) Capsule 2.38 S.O. 644(E) w.e.f Dapsone P,S,T Tablet 25 mg Tablet 50 mg YES 1 Tablet 0.21 S.O. 644(E) w.e.f Tablet 100 mg YES 1 Tablet 0.23 S.O. 644(E) w.e.f Rifampicin P,S,T Capsule 150 mg YES 1 Capsule 1.82 S.O. 2730(E) Capsule 1.88 S.O. 644(E) w.e.f Capsule 300 mg YES 1 Capsule 3.37 S.O. 2730(E) Capsule 3.4 S.O. 644(E) w.e.f Antituberculosis medicines Capreomycin P,S,T Powder for Injection 1 g EACH PACK S.O. 1405(E) Immediate Cycloserine P,S,T Capsule 120 mg 6

8 Capsule 250 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Cycloserine Tablet Cycloserine-250mg 1 Tablet S.O. 1687(E) Immediate Ethambutol P,S,T Tablet 200 mg YES 1 Tablet 0.94 S.O.2569(E) Tablet 1.04 S.O. 644(E) w.e.f Tablet 400 mg YES 1 Tablet 2.14 S.O.2569(E) Tablet 2.33 S.O. 644(E) w.e.f Tablet 600 mg YES 1 Tablet 3.15 S.O.2569(E) Tablet 3.39 S.O. 644(E) w.e.f Tablet 800 mg YES 1 Tablet 3.77 S.O.2195(E) Tablet 4.02 S.O. 644(E) w.e.f Ethionamide P,S,T Tablet 125 mg Tablet 250 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Isoniazid P,S,T Tablet 50 mg YES Tablet 100 mg YES 1 Tablet 0.78 S.O. 644(E) w.e.f Tablet 300 mg YES 1 Tablet 1.36 S.O. 1461(E) S.O (E) Withdrawn immediately 1 Tablet 1.86 S.O. 1253(E) w.e.f Tablet 1.91 S.O. 1253(E) Immediate 1 Tablet 1.36 S.O. 644(E) w.e.f Oral liquid 100 mg/5 ml YES 1 ml 0.23 S.O. 644(E) w.e.f Kanamycin P,S,T Powder for Injection 500 mg EACH PACK S.O. 2962(E) Powder for Injection 750 mg EACH PACK S.O. 1405(E) Immediate Powder for Injection 1 g EACH PACK S.O. 1405(E) Immediate Levofloxacin P,S,T Tablet 250 mg 1 Tablet 4.09 S.O. 1253(E) w.e.f Tablet 4.20 S.O. 1253(E) Immediate Tablet 500 mg 1 Tablet 6.23 S.O. 1253(E) w.e.f Tablet 6.40 S.O. 1253(E) Immediate Tablet 750 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Linezolid P,S,T Tablet 600 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Moxifloxacin P,S,T Tablet 200 mg Tablet 400 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Para-amino salicylic acid P,S,T Tablet 500 mg Granules (As licensed) Pyrazinamide P,S,T Tablet 500 mg YES 1 Tablet 3.77 S.O.2195(E) Tablet 4.05 S.O. 644(E) w.e.f Tablet 750 mg YES 1 Tablet 5.73 S.O.2195(E) Tablet 7.42 S.O. 644(E) w.e.f Tablet 1000 mg YES 1 Tablet 8.39 S.O.2195(E) Tablet 8.91 S.O. 644(E) w.e.f Tablet 1500 mg YES 1 Tablet 9.29 S.O.2569(E) Tablet S.O. 644(E) w.e.f Oral liquid 250 mg/5 ml Rifabutin S,T Capsule 150 mg Rifampicin P,S,T Capsule 150 mg YES 1 Capsule 1.82 S.O. 2730(E) Capsule 1.88 S.O. 644(E) w.e.f Capsule 300 mg YES 1 Capsule 3.37 S.O. 2730(E) Capsule 3.4 S.O. 644(E) w.e.f Capsule 450 mg YES 1 Capsule 4.43 S.O. 2730(E) Capsule 4.92 S.O. 644(E) w.e.f Capsule 600 mg 1 Capsule S.O. 1253(E) w.e.f Capsule S.O. 1253(E) Immediate Oral liquid 100 mg/5 ml YES 1 ml 0.34 S.O. 644(E) w.e.f Streptomycin P,S,T Powder for Injection 750 mg YES Each Pack 7.82 S.O.3181(E) EACH PACK 8.49 S.O. 644(E) w.e.f Powder for Injection 1 g YES EACH PACK S.O. 644(E) w.e.f Antifungal medicines Amphotericin B a) Amphotericin B (conventional) S,T Powder for Injection 50 mg YES EACH PACK S.O. 644(E) w.e.f b) Lipid Liposomal Amphotericin B Clotrimazole P,S,T Pessary 100 mg YES 1 Pessaries 9.34 S.O. 644(E) w.e.f Fluconazole P,S,T Tablet 100 mg YES 1 Tablet 7.40 S.O.2569(E)

9 1 Tablet S.O. 644(E) w.e.f Tablet 150 mg YES 1 Tablet S.O. 1351(E) Tablet S.O. 644(E) w.e.f Tablet 200 mg YES 1 Tablet S.O.2195(E) Tablet S.O. 644(E) w.e.f Tablet 400 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Oral liquid 50 mg/5 ml S,T Injection 200 mg/100 ml EACH PACK S.O. 1405(E) Immediate Griseofulvin P,S,T Tablet 125 mg YES 1 Tablet 0.76 S.O. 644(E) w.e.f Tablet 250 mg YES 1 Tablet 1.48 S.O.2195(E) Tablet 1.56 S.O. 644(E) w.e.f Tablet 375 mg Nystatin P,S,T Tablet 500,000 IU YES Pessary 100,000 IU YES Oral liquid 100, 000 IU/ml 6.4-Antiviral medicines Antiherpes medicines Acyclovir P,S,T Tablet 200 mg YES 1 Tablet 6.29 S.O.2195(E) Tablet 7.84 S.O. 644(E) w.e.f Tablet 400 mg YES 1 Tablet S.O.2195(E) Tablet S.O. 644(E) w.e.f Powder for Injection 250 mg YES EACH PACK S.O. 644(E) w.e.f Powder for Injection 500 mg YES EACH PACK 466 S.O. 644(E) w.e.f Oral liquid 400 mg/5 ml YES 1 ml 1.41 S.O. 644(E) w.e.f Anti Cytomegalovirus (CMV) medicines Ganciclovir S,T Capsule 250 mg Powder for Injection 500 mg Each Pack S.O.3180 (E) Antiretroviral medicines Nucleoside reverse transcriptase inhibitors Abacavir S,T Tablet 60 mg Tablet 300 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Abacavir (A) + Lamivudine (B) S,T Tablet 60 mg (A) + 30 mg (B) Tablet 600 mg (A)+ 300 mg (B) 1 Tablet S.O. 1817(E) Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Lamivudine (A) + Nevirapine (B) + Stavudine S,T Dispersible Tablet 30 mg (A) + 50 mg (B) + 6 mg Tablet 150 mg (A) mg (B) + 30 mg YES 1 Tablet S.O. 644(E) w.e.f Lamivudine (A) + Zidovudine (B) S,T Tablet 30 mg (A) + 60 mg (B) Tablet 150 mg (A)+ 300 mg (B) YES 1 Tablet S.O.2569(E) Tablet S.O. 644(E) w.e.f Stavudine (A) + Lamivudine (B) S,T Dispersible Tablet 6 mg (A) + 30 mg (B) 30 mg (A) mg (B) YES 1 Tablet 8.86 S.O.2569(E) Tablet 9.88 S.O. 644(E) w.e.f Tenofovir (A) + Lamivudine (B) S,T Tablet 300 mg (A) mg (B) 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Tenofovir (A) + Lamivudine (B) + Efavirenz (C) S,T Tablet 300 mg (A) mg (B) mg S.O. 1253(E) w.e.f Tablet Tablet S.O. 1253(E) Immediate Zidovudine S,T Tablet 300 mg YES 1 Tablet S.O.2569(E) Tablet S.O. 644(E) w.e.f Oral liquid 50 mg/5 ml Zidovudine (A) + Lamivudine (B) + Nevirapine S,T 60 mg (A) + 30 mg (B) + 50 mg 300 mg (A) mg (B) mg YES 1 Tablet S.O. 644(E) w.e.f Non-nucleoside reverse transcriptase inhibitors Efavirenz S,T Tablet 50 mg Tablet 200 mg Tablet 600 mg 1 Tablet S.O. 2729(E) Nevirapine S,T Dispersible Tablet 50 mg Tablet 200 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Oral liquid 50 mg/5 ml YES 8

10 1 ml 1.05 S.O. 644(E) w.e.f Integrase inhibitors Raltegravir S,T Tablet 400 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Protease Inhibitors Atazanavir (A) + Ritonavir (B) S,T Tablet 300 mg (A) mg (B) 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Darunavir S,T Tablet 600 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Lopinavir (A) + Ritonavi (B) S,T Tablet 100 mg (A) + 25 mg (B) Tablet 200 mg (A) + 50 mg (B) 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Oral liquid 400mg (A) + 100mg (B)/5ml Ritonavir S,T Tablet 100 mg 1 Tablet S.O. 2729(E) Medicines for hepatitis B and hepatitis C Entecavir S,T Tablet 0.5 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Tablet 1 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Pegylated interferon alfa 2a S,T Injection 180 mcg S,T Injection 80 mcg Pegylated Interferon alfa 2b Injection Pegylated Interferon alfa 2b- 80mcg EACH PACK S.O. 1687(E) Immediate Injection 100 mcg Pegylated Interferon alfa 2b Injection Pegylated Interferon alfa 2b- 100mcg EACH PACK S.O. 1687(E) Immediate Injection 120 mcg Ribavirin S,T Capsule 200 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Sofosbuvir S,T Tablet 400 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Tenofovir S,T Tablet 300 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Section 6.5 Antiprotozoal Medicines Antiamoebic and antigiardiasis medicines Diloxanide furoate P,S,T Tablet 500 mg YES 1 Tablet 1.73 S.O. 644(E) w.e.f Metronidazole P,S,T Tablet 200 mg YES 1 Tablet 0.40 S.O.2195(E) Tablet 0.45 S.O. 644(E) w.e.f P,S,T Tablet 400 mg YES 1 Tablet 0.75 S.O. 1819(E) Immediate 1 Tablet 0.81 S.O. 644(E) w.e.f P,S,T Injection 500 mg/100 ml YES 1 ml S.O. 644(E) w.e.f P,S,T Oral liquid 200 mg/5 ml 1 ml 0.27 S.O.3182 (E) ml 0.25 S.O. 1561(E) Immediate Antileishmaniasis medicines Amphotericin B a) Amphotericin B S,T Powder for Injection 50 mg (conventional) b) Lipid/ Liposomal Amphotericin B Miltefosine P,S,T Capsule 10 mg P,S,T Capsule 50 mg Paromomycin P,S,T Injection 375 mg/ml Antimalarial medicines For curative treatment Artemether (A) + Lumefantrine (B) P,S,T Tablet 20 mg (A) mg (B) 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate P,S,T Tablet 40 mg (A) mg (B) 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate P,S,T Tablet 80 mg (A) mg (B) 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate P,S,T Oral liquid 80 mg (A) mg (B)/5 ml Artesunate P,S,T Powder for Injection 60 mg EACH PACK S.O. 1405(E) Immediate P,S,T Powder for Injection 120 mg EACH PACK S.O. 1405(E) Immediate Artesunate (A) + Sulphadoxine - Pyrimethamine (B) P,S,T Tablet Combi pack (A+B) 1 Tablet 25 mg (A) + 1 Tablet (250 mg mg) (B) Tablet Combi pack (A+B) 1 Tablet 50 mg (A) + 1 Tablet (500 mg + 25 mg) (B) Tablet Combi pack (A+B) 1 Tablet 100 mg (A) + 1 Tablet (750 mg mg) (B) 9

11 Tablet Combi pack (A+B) 1 Tablet 150 mg (A) + 2 Tablet (500 mg + 25 mg) (B) Tablet Combi pack (A+B) 1 Tablet 200 mg (A) + 2 Tablet (750 mg mg) (B) Chloroquine P,S,T Tablet 150 mg YES 1 Tablet 0.76 S.O. 644(E) w.e.f Oral liquid 50 mg/5 ml YES 1 ml 0.26 S.O. 644(E) w.e.f Clindamycin P,S,T Capsule 150 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate P,S,T Capsule 300 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Clindamycin Tablet Clindamycin-300mg YES 1 Tablet S.O. 1686(E) Immediate 1 Tablet S.O. 644(E) w.e.f Primaquine P,S,T Tablet 2.5 mg YES 1 Tablet 1.44 S.O. 2963(E) Tablet 1.66 S.O. 644(E) w.e.f Tablet 7.5 mg YES 1 Tablet 1.96 S.O. 2730(E) Tablet 2.13 S.O. 644(E) w.e.f Tablet 15 mg 1 Tablet 4.26 S.O. 2729(E) Quinine P,S,T Tablet 300 mg YES 1 Tablet 5.09 S.O.2195(E) Tablet 5.48 S.O. 644(E) w.e.f Injection 300 mg/ml YES 1 ml 9.74 S.O. 644(E) w.e.f Mefloquine T Tablet 250 mg *Only for use as chemoprophylaxis for long term travellers like military and travel troops, travelling from low endemic to high endemic area Co-trimoxazole [Sulphamethoxazole (A) + Trimethoprim (B)] For prophylaxis Antipneumocystosis and antitoxoplasmosis medicines P,S,T Tablet 400 mg (A) + 80 mg (B) YES YES 1 Tablet S.O.2195(E) Tablet S.O. 644(E) w.e.f Tablet 0.62 S.O. 644(E) w.e.f Tablet 800 mg (A) mg (B) YES 1 Tablet 1.33 S.O. 644(E) w.e.f Oral liquid 200 mg (A) + 40 mg (B)/5 ml YES 1 ml 0.28 S.O. 644(E) w.e.f Pentamidine S,T Powder for Injection 200 mg Section 7 Antimigraine medicines YES 1 Tablet 0.21 S.O. 644(E) w.e.f Acetylsalicylic acid P,S,T Tablet 300 mg to 500 mg 300 mg 325 mg YES 1 Tablet 0.73 S.O. 644(E) w.e.f mg YES 300 mg to 500 mg Effervescent/ Dispersible/ Enteric coated Tablet Paracetamol P,S,T Tablet 500 mg YES 1 Tablet 0.83 S.O. 1351(E) Tablet 1.01 S.O. 644(E) w.e.f Tablet 650 mg 1 Tablet 1.71 S.O. 1253(E) w.e.f Tablet 1.76 S.O. 1253(E) Immediate Sumatriptan P,S,T Tablet 25 mg Tablet 50 mg Injection 6 mg/ 0.5 ml 7.2 For prophylaxis Flunarizine P,S,T Tablet 5 mg 1 Tablet 2.56 S.O. 1253(E) w.e.f Tablet 2.63 S.O. 1253(E) Immediate Tablet 10 mg 1 Tablet 4.38 S.O. 1253(E) w.e.f Tablet 4.50 S.O. 1253(E) Immediate Propranolol P,S,T Tablet 10 mg YES 1 Tablet 1.07 S.O.2195(E) Tablet 1.17 S.O. 644(E) w.e.f Tablet 40 mg YES 1 Tablet 2.59 S.O. 1351(E) Tablet 2.74 S.O. 644(E) w.e.f Propranolol Capsule Propranolol - 40 mg 1 Capsule 3.53 S.O.3180 (E) Tablet 80 mg 1 Tablet 4.63 S.O. 1253(E) w.e.f Tablet 4.76 S.O. 1253(E) Immediate Propranolol Capsule Propranolol -80mg 1 Capsule 5.35 S.O. 1687(E) Immediate Section 8 Antineoplastic/ immunosuppressives and medicines used in palliative care 8.1 Antineoplastic medicines Fluorouracil T Injection 250 mg/5 ml YES 1 ml 2.24 S.O. 644(E) w.e.f Mercaptopurine T Tablet 50 mg Actinomycin D T Powder for Injection 0.5 mg YES 10

12 1 Injection S.O. 644(E) w.e.f All-trans retinoic acid T Capsule 10 mg Arsenic trioxide T Injection 1mg/ml Bleomycin T Powder for Injection 15 units YES Each Pack S.O.3181(E) ml S.O. 644(E) w.e.f Bortezomib T Powder for Injection 2mg EACH PACK S.O. 1405(E) Immediate Calcium folinate T Tablet 15 mg 1 Tablet S.O. 1405(E) Immediate Injection 3 mg/ml Capecitabine T Tablet 500 mg 1 Tablet S.O. 1561(E) Immediate Carboplatin T Injection 10 mg/ml YES 1 ml S.O. 1560(E) Immediate EACH PACK S.O. 644(E) w.e.f Chlorambucil T Tablet 2 mg YES 1 Tablet S.O.2569(E) Tablet S.O. 644(E) w.e.f Tablet 5 mg 1 Tablet S.O. 1405(E) Immediate Cisplatin T Injection 1mg/ml YES 1 ml 6.39 S.O. 1560(E) Immediate Each Pack S.O. 644(E) w.e.f Cyclophosphamide T Tablet 50 mg YES 1 Tablet 3.61 S.O.2569(E) Tablet 4.03 S.O. 644(E) w.e.f Tablet 200 mg YES Powder for Injection 500 mg YES Each Pack S.O.3181(E) Injectable S.O. 644(E) w.e.f Cytosine arabinoside T Injection 100 mg/ ml YES EACH PACK S.O. 644(E) w.e.f Powder for Injection 500 mg YES EACH PACK S.O. 644(E) w.e.f Powder for Injection 1000 mg YES EACH PACK S.O. 644(E) w.e.f Dacarbazine T Powder for Injection 500 mg YES Each Pack S.O.3181(E) EACH PACK S.O. 644(E) w.e.f Powder for Injection 200 mg EACH PACK S.O. 1405(E) Immediate Daunorubicin T Injection 5 mg/ml Docetaxel T Powder for Injection 20 mg EACH PACK S.O. 1405(E) Immediate Powder for Injection 80 mg EACH PACK S.O. 1405(E) Immediate Doxorubicin T Injection 2 mg/ml YES 1 ml S.O. 1686(E) Immediate EACH PACK S.O. 644(E) w.e.f Etoposide T Capsule 50 mg Capsule 100 mg YES 1 Capsule S.O. 644(E) w.e.f Injection 20 mg/ml YES EACH PACK S.O. 644(E) w.e.f Gefitinib T Tablet 250 mg 1 Tablet S.O. 1405(E) Immediate Gemcitabine T Powder for Injection 200 mg YES EACH PACK S.O. 644(E) w.e.f Powder for Injection 1 g YES EACH PACK S.O. 1404(E) Immediate EACH PACK S.O. 644(E) w.e.f Ifosfamide T Powder for Injection 1 g YES EACH PACK S.O. 644(E) w.e.f Powder for Injection 2 g Imatinib T Tablet 100 mg YES 1 Tablet S.O. 2730(E) Tablet S.O. 644(E) w.e.f Imatinib Capsules Imatinib mg 1 Capsule S.O.3180 (E) Tablet 400 mg YES 1 Tablet S.O. 1351(E) Tablet S.O. 644(E) w.e.f L-Asparaginase T Powder for Injection 5000 KU. YES EACH PACK S.O. 644(E) w.e.f Powder for Injection KU EACH PACK S.O. 1405(E) Immediate Melphalan T Tablet 2 mg YES 1 Tablet S.O.2569(E) Tablet S.O. 644(E) w.e.f Tablet 5 mg YES 1 Tablet S.O.2569(E) Tablet S.O. 644(E) w.e.f Mesna T Injection 100 mg/ml 1 ml S.O. 1561(E) Immediate Methotrexate T Tablet 2.5 mg YES 1 Tablet 4.26 S.O.2195(E) Tablet 5.07 S.O. 644(E) w.e.f Tablet 5 mg YES 1 Tablet 7.45 S.O. 2963(E) Tablet 8.16 S.O. 644(E) w.e.f Tablet 10 mg YES 1 Tablet S.O.2195(E) Tablet S.O. 644(E) w.e.f Injection 50 mg/ml YES 1 ml S.O. 644(E) w.e.f Oxaliplatin T Injection 5 mg/ml Paclitaxel T Injection 30 mg/5 ml YES 1 ml S.O. 1560(E) Immediate 1 ml S.O. 644(E) w.e.f Injection 100 mg/16.7 ml 1 ml S.O. 1561(E) Immediate 11

13 Procarbazine T Capsule 50 mg YES 1 Capsule S.O. 2730(E) Capsule S.O. 644(E) w.e.f Rituximab T Injection 10 mg/ml 1 ml S.O. 1405(E) Immediate Temozolomide T Capsule 20 mg 1 Capsule S.O. 1405(E) Immediate Temozolomide Tablet Temozolomide -20mg 1 Tablet S.O. 1687(E) Immediate Capsule 100 mg 1 Capsule S.O. 1405(E) Immediate Temozolomide Tablet Temozolomide -100mg 1 Tablet S.O. 1687(E) Immediate Capsule 250 mg 1 Capsule S.O. 1405(E) Immediate Temozolomide Tablet Temozolomide -250mg 1 Tablet S.O. 1687(E) Immediate Thalidomide T Capsule 50 mg 1 Capsule S.O. 1405(E) Immediate Capsule 100 mg 1 Capsule S.O. 1405(E) Immediate Trastuzumab T Injection 440 mg/50 ml EACH PACK S.O. 1687(E) Immediate Vinblastine T Injection 1 mg/ml Vincristine T Injection 1 mg/ml YES 1 ml S.O.3181(E) EACH PACK S.O. 644(E) w.e.f Hormones and antihormones used in cancer therapy Bicalutamide T Tablet 50 mg 1 Tablet S.O. 1405(E) Immediate Letrozole T Tablet 2.5 mg 1 Tablet S.O. 1405(E) Immediate Prednisolone S, T Tablet 10 mg YES 1 Tablet 0.90 S.O. 1819(E) Immediate 1 Tablet 0.99 S.O. 644(E) w.e.f Tablet 20 mg YES 1 Tablet 1.81 S.O.2195(E) Tablet 1.85 S.O. 644(E) w.e.f Tablet 40 mg Oral liquid 5 mg/5 ml 1 ml 0.40 S.O. 1561(E) Immediate Oral liquid 15 mg/5 ml 1 ml 0.71 S.O. 1561(E) Immediate Injection 20 mg/2 ml Tamoxifen T Tablet 10 mg YES 1 Tablet 2.39 S.O. 2730(E) Tablet 4.67 S.O. 644(E) w.e.f Tablet 20 mg YES 1 Tablet 2.70 S.O. 2730(E) Tablet 2.98 S.O. 644(E) w.e.f Immunosuppressive medicines Azathioprine T Tablet 50 mg YES 1 Tablet 9.02 S.O. 1351(E) Tablet S.O. 644(E) w.e.f Cyclosporine T Capsule 10 mg YES Capsule 25 mg YES 1 Capsule S.O. 2963(E) Capsule S.O. 644(E) w.e.f Capsule 50 mg YES 1 Capsule S.O.2195(E) Capsule S.O. 644(E) w.e.f Capsule 100 mg YES 1 Capsule S.O.2195(E) Capsule S.O. 644(E) w.e.f Oral liquid 100 mg/ml 1 ml S.O. 2730(E) ml S.O. 1561(E) Immediate Injection 50 mg/ml Mycophenolate mofetil T Tablet 250 mg 1 Tablet S.O. 1405(E) Immediate Tablet 500 mg 1 Tablet S.O. 1405(E) Immediate Tacrolimus T Capsule 0.5 mg 1 Capsule S.O. 1405(E) Immediate Capsule 1 mg 1 Capsule S.O. 1405(E) Immediate Capsule 2 mg 1 Capsule S.O. 1405(E) Immediate 8.4 Medicines used in palliative care Allopurinol T Tablet 100 mg YES 1 Tablet 1.76 S.O. 1351(E) Tablet 2.25 S.O. 644(E) w.e.f Amitriptyline T Tablet 10 mg 1 Tablet 2.13 S.O. 1405(E) Immediate Tablet 25 mg YES 1 Tablet 2.10 S.O.2195(E) Tablet 2.28 S.O. 644(E) w.e.f Dexamethasone T Tablet 0.5 mg YES 1 Tablet 0.18 S.O. 1819(E) Immediate 1 Tablet 0.20 S.O. 644(E) w.e.f Injection 4 mg/ml YES 1 ml 2.69 S.O. 644(E) w.e.f Diazepam T Tablet 2 mg YES 1 Tablet 1.39 S.O.2569(E) Tablet 1.55 S.O. 644(E) w.e.f Tablet 5 mg YES 1 Tablet 1.32 S.O.2569(E) Tablet 1.41 S.O. 644(E) w.e.f Injection 5 mg/ml YES 1 ml 5.62 S.O.3181(E) ml 6 S.O. 644(E) w.e.f Filgrastim T Injection 300 mcg EACH PACK S.O. 1405(E) Immediate Fluoxetine T Capsule 20 mg YES 1 Capsule 3.38 S.O.2195(E) Capsule 3.73 S.O. 644(E) w.e.f Fluoxetine Tablet Tablet - 20 mg 1 Tablet 3.68 S.O.3180 (E) Haloperidol T Tablet 1.5 mg 1 Tablet 1.53 S.O. 1405(E) Immediate Tablet 5 mg 1 Tablet 3.19 S.O. 1405(E) Immediate Injection 5 mg/ml YES 1 ml 5.41 S.O.3181(E) ml 6.05 S.O. 644(E) w.e.f Lactulose T Oral liquid 10 g/15 ml 1 ml 0.98 S.O. 1561(E) Immediate 12

14 8.4.9 Loperamide T Tablet 2 mg 1 Tablet 1.83 S.O. 1405(E) Immediate Loperamide Capsule Loperamide-2mg 1 Capsule 3.32 S.O. 1687(E) Immediate Metoclopramide T Tablet 10 mg YES 1 Tablet 1.08 S.O.2569(E) Tablet 1.12 S.O. 644(E) w.e.f Oral liquid 5 mg/5 ml YES 1 ml 0.51 S.O. 644(E) w.e.f Injection 5 mg/ ml YES 1 ml 2.25 S.O. 644(E) w.e.f Midazolam T Injection 1 mg/ml YES 1 ml 6.23 S.O. 644(E) w.e.f Morphine T Tablet 10 mg YES 1 Tablet 5.42 S.O. 644(E) w.e.f Tablet 20 mg SR Tablet 30 mg Ondansetron S,T Tablet 4 mg YES 1 Tablet 4.35 S.O. 1351(E) Tablet 5.11 S.O. 644(E) w.e.f Tablet 8 mg YES 1 Tablet 9.06 S.O.2195(E) Tablet S.O. 644(E) w.e.f Oral liquid 2 mg/5 ml YES 1 ml 1.04 S.O.3181(E) ml 1.12 S.O. 644(E) w.e.f Injection 2 mg/ ml YES 1 ml 5.43 S.O. 1351(E) ml 7.92 S.O. 644(E) w.e.f Tramadol T Capsule 50 mg YES 1 Capsule 4.20 S.O.2195(E) Capsule 6.48 S.O. 644(E) w.e.f Capsule 100 mg YES Tramadol Tablet Tramadol-100mg 1 Tablet S.O. 1687(E) Immediate Injection 50 mg/ml YES 1 ml 12.6 S.O. 644(E) w.e.f Zoledronic acid T Powder for Injection 4 mg Section 9 Antiparkinsonism medicines 9.1 Levodopa (A) + Carbidopa (B) P,S,T Tablet 100 mg (A) + 10 mg (B) YES 1 Tablet 1.44 S.O. 1819(E) Immediate 1 Tablet 1.62 S.O. 644(E) w.e.f Tablet 100 mg (A) + 25 mg (B) YES 1 Tablet 2.10 S.O. 1819(E) Immediate 1 Tablet 2.29 S.O. 644(E) w.e.f CR Tablet 100 mg (A) + 25 mg (B) 1 Tablet 3.10 S.O. 1253(E) w.e.f Tablet 3.19 S.O. 1253(E) Immediate CR Tablet 200 mg (A) + 50 (B) mg Tablet 250 mg (A) + 25 mg (B) YES 1 Tablet 3.46 S.O. 2963(E) Tablet 3.89 S.O. 644(E) w.e.f Trihexyphenidyl P,S,T Tablet 2 mg YES 1 Tablet 1.13 S.O. 1351(E) Tablet 1.47 S.O. 644(E) w.e.f Section 10 Medicines affecting blood 10.1 Antianaemia medicines Erythropoietin S,T Injection 2000 IU/ml EACH PACK S.O. 1405(E) Immediate Injection IU/ml EACH PACK S.O. 1405(E) Immediate Ferrous salts P,S,T Tablet equivalent to 60 mg of elemental iron YES Oral liquid equivalent to 25 mg of elemental iron/ml YES Ferrous salt (A) + Folic acid (B) P,S,T Tablet 45mg elemental iron (A) mcg (B) Tablet 100 mg elemental iron (A) mcg (B) Oral liquid 20 mg elemental iron (A) mcg (B)/ml Folic acid P,S,T Tablet 5 mg YES 1 Tablet 1.28 S.O. 1819(E) Immediate 1 Tablet 1.48 S.O. 644(E) w.e.f Hydroxocobalamin P,S,T Injection 1 mg/ml Hydroxyurea P,S,T Capsule 500 mg 1 Tablet S.O. 1253(E) w.e.f Tablet S.O. 1253(E) Immediate Iron sucrose S,T Injection 20 mg/ml 1 ml S.O. 1405(E) Immediate 10.2 Medicines affecting coagulation Enoxaparin T Injection 40 mg/0.4 ml YES 0.1 ml S.O. 2963(E) EACH PACK S.O. 644(E) w.e.f Injection 60 mg/0.6 ml YES 0.1 ml S.O. 2963(E) EACH PACK S.O. 644(E) w.e.f Heparin S,T Injection 1000 IU/ml YES 1 ml S.O. 644(E) w.e.f Injection 5000 IU/ml YES 1 ml S.O. 644(E) w.e.f Phytomenadione (Vitamin K1) P,S,T Tablet 10mg Injection 10 mg/ml YES 13

(To be Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary)

(To be Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) (To be Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical

More information

(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary)

(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) (Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical

More information

THE DRUGS (PRICES CONTROL) ORDER, 2013

THE DRUGS (PRICES CONTROL) ORDER, 2013 THE DRUGS (PRICES CONTROL) ORDER, 2013 (Notified by SO 1221 (E) dated 15.05.2013 and as amended up to vide SO 1192(E) dated 22-03-2016) In exercise of the powers conferred by section 3 of the Essential

More information

Ministry of Chemicals and Fertilizers. (Department of Pharmaceuticals) ORDER

Ministry of Chemicals and Fertilizers. (Department of Pharmaceuticals) ORDER Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals) New Delhi, Dated 15th May 2013 ORDER S.O. 1221(E). In exercise of the powers conferred by section 3 of the Essential Commodities Act,

More information

CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs

CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs page 1 CURRENT WORK PLAN New monographs for inclusion in The International Pharmacopoeia and revision of related monographs 2011 The following categories are included in this work programme: 1. Medicines

More information

DISCLAIMER (Updated as on )

DISCLAIMER (Updated as on ) DISCLAIMER The information contained herein is not a substitute to ceiling prices notified in the Gazette of India Extraordinary. For the official version, please refer to the relevant Gazette Notification

More information

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and

5 Infections. To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and 5 Infections To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and Southend University Hospital, Antibiotic Guidelines Index 5.1 Antibacterial drugs

More information

OF NOTIFIED CEILING PRICES OF SCHEDULED DRUGS

OF NOTIFIED CEILING PRICES OF SCHEDULED DRUGS ISO 9001 : 2008 Certified Affordable Medicine for All COMPENDIUM OF NOTIFIED CEILING PRICES OF SCHEDULED DRUGS (AS ON 31ST JANUARY, 2015) National Pharmaceutical Pricing Authority Department of Pharmaceuticals

More information

Rajasthan Medical Services Corporation Limited, Jaipur

Rajasthan Medical Services Corporation Limited, Jaipur Rajasthan Medical Services Corporation Limited, Jaipur List of Drugs- Purchase order placed to successful Bidders Tendered on 05/07/2011 S.No. Name of Drug 1 Atropine Sulphate Injection 0.6 mg /ml (SC/IM/IV

More information

WHO Model List (revised April 2002)

WHO Model List (revised April 2002) Essential Medicines Explanatory Notes The complementary list presents essential medicines for priority diseases which are efficacious, safe and cost-effective but not necessarily affordable, or for which

More information

To be published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section(ii) dated 15 th May 2013 ORDER

To be published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section(ii) dated 15 th May 2013 ORDER To be published in the Gazette of India, Extraordinary, Part II, Section 3, Sub-section(ii) dated 15 th May 2013 Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals) New Delhi Dated 15

More information

Appendix 4: Renal impairment

Appendix 4: Renal impairment Appendix 4: Renal impairment Reduced renal function may cause problems with drug therapy for the following reasons: 1. The failure to excrete a drug or its metabolites may produce toxicity. 2. The to some

More information

poor solubility and poor permeability unknown whether poor BA is due to poor solubility or antiglaucoma medicine for biowaiver Not eligible

poor solubility and poor permeability unknown whether poor BA is due to poor solubility or antiglaucoma medicine for biowaiver Not eligible Table 1 Substances on the WHO Model List of Essential Medicines (EML) Medicine a abacavir 200 mg high low 3 9.2.1.2 antiretroviral acetazolamide 250 mg low low (?) 4/2 antiglaucoma acetylsalicylic acid

More information

Chapter 5 ~ Infections

Chapter 5 ~ Infections Chapter 5 ~ Infections: Special Section 1 of 6 Chapter 5 ~ Infections Please refer to The Hillingdon Hospitals NHS Trust Antibiotic Guidelines, Policy number 233, and Surgical Prophylaxis Policy, Policy

More information

EML 14 COMPLEMENTARY LIST

EML 14 COMPLEMENTARY LIST 1. ANAESTHETICS 1.1 General anaesthetics and oxygen 1.2 Local anaesthetics ephedrine injection, 30mg (hydrochloride)/ml in 1-ml (see comment) 3mg/ml in 1mL, 10mL For reversal of hypotension from epidural

More information

Appendix 5: Hepatic impairment

Appendix 5: Hepatic impairment Appendix 5: Hepatic impairment Liver disease may alter the response to drugs. However, the hepatic reserve appears to be large and liver disease has to be severe before important changes in drug metabolism

More information

1. PROCEDURE FOR THIS INVITATION TO EOI 2. APIS INCLUDED IN THE 14TH INVITATION. Guidance Document 11 April 2017

1. PROCEDURE FOR THIS INVITATION TO EOI 2. APIS INCLUDED IN THE 14TH INVITATION. Guidance Document 11 April 2017 To support national and global efforts to increase access to and the affordability of care and treatment of HIV/AIDS, hepatitis B and C, tuberculosis, malaria, neglected tropical diseases, influenza, diarrhoea

More information

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS

ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS GIT PRODUCTS SR. NO 1 ANTI COLD / ANTI ALLERGIC / ANTI-ASTHMATICS Paracetamol 500 mg, Phenylephrine HCL 5 mg With Chlorpheniramine Maleate 2 mg & Caffeine 30 mg Tablets 2 Salbutamol Tablets BP 2 mg 3 Salbutamol Tablets

More information

VMG Pharmaceuticals Pvt. Ltd.

VMG Pharmaceuticals Pvt. Ltd. S. No. Product Name S trength Dos age form Oncology 1 A nastrazole 1 mg Tablets 2 Bicalutamide 50 mg Tablets 3 Bleomycin 15units,30units Injection 4 Bortezomib 3.5 mg Injection 5 Capecitabine 500 mg Tablets

More information

1. Procedure for this Invitation to EOI. 2. Medicinal products included on the 14 th Invitation. Guidance Document 14 May 2016

1. Procedure for this Invitation to EOI. 2. Medicinal products included on the 14 th Invitation. Guidance Document 14 May 2016 To support national and global efforts to increase access to and the affordability of HIV/AIDS-related care and treatment together with UNICEF, UNAIDS and UNITAID, invite applicants for selected pharmaceutical

More information

Appendix 1: Interactions

Appendix 1: Interactions Appendix 1: Interactions Two or more drugs given at the same time may interact with each other. The interaction may be potentiation or antagonism of one drug by another, or occasionally some other. Drug

More information

NIT 97 - APPROVED DRUG LIST

NIT 97 - APPROVED DRUG LIST 1 EDL0422 Name of the and Strength Chlorine based compound NADCC Tablets 75 mg With Available Chloroine 45 mg BIS* 1 pack of 1000 tablets VAT 440748 71.0000 74.5500 ADHISH INDUSTRIES 2 120092 Cloxacillin

More information

Invitation to Manufacturers 16 August 2017

Invitation to Manufacturers 16 August 2017 Invitation to Manufacturers 16 August 2017 Manufacturers of Antiretroviral (HIV/AIDS), Antihepatitis B and C, Antituberculosis and Antimalarial medicines Are Invited to Submit An Expression of Interest

More information

LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No.

LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR (Non-Prequalified Items) A: Injection Antimicrobials Sr. No. LIST OF DRUGS / MEDICINES ITEMS FOR THE YEAR 2017-2018 (Non-Prequalified Items) A: Injection Antimicrobials Sr. 1 Amphotericin B vial of 50mg with wfi individually packed in carton with 2 Artemether 80mg/ml

More information

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy

Supply should only occur if requesting signature is on approved list held by the issuing pharmacy Trust Approved Drugs List March 2016 The following is the list of drugs that are approved by the EEAST Medicines Management Group for use by EEAST clinical staff. Pharmacies are advised that this is the

More information

OFFERâ S INJECTABLES

OFFERâ S INJECTABLES A B Page 6 7 8 9 0 C 6 7 Page 8 9 0 D E Page 6 7 8 9 F Page 6 7 8 9 G H Page 6 7 8 9 I 6 7 Page 6 8 9 0 J 6 7 Page 7 K 6 7 8 9 L Page 8 6 7 8 9 0 Page 9 6 7 8 9 0 Page 0 OFFERâ S INJECTABLES Alimentary

More information

COST CONSIDERATIONS Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines!!!!!!!!!

COST CONSIDERATIONS Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines!!!!!!!!! UICCEMLCostingScenarios BackoftheEnvelope Calculations PreparedforWorkingGroupSession:19621November2014,Geneva MethodsSummary We have chosen a conservative approach, calculating cost per vial. We have

More information

قائمة األدوية األساسية للمملكة العربية السعودية

قائمة األدوية األساسية للمملكة العربية السعودية قائمة األدوية األساسية للمملكة العربية السعودية النسخة الثانية 2018 Essential Medicines of Saudi Arabia 2 nd List -2018 Class Generic Name Dosage Form Strength (Volume) 1 Anesthetics, Preoperative Medicines.

More information

What s New

What s New What s New 23.12.2016 NPPA has fixed/revised ceiling prices of 55 scheduled formulations of Schedule-I under Drugs ( Control) Amendment Order,2016 and Retail of 29 formulations under DPCO, 2013 in related

More information

Cumulative Receipt of the financial year

Cumulative Receipt of the financial year Name of the Heath facility & Category :..... Monthly stock statement cum Indent form Uttar Pradesh Medical Supplies Corporation Ltd Department of Health & Family Welfare, Govt of Uttar Pradesh Date:...

More information

REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO

REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO REIMBURSEMENT STATUS OF HIV MEDICATIONS IN ONTARIO Ont. Drug Distr. Ontario Drug Benefit/Trillium: Other Formulary (F/A) Limited Use (Section 16) Antiretrovirals AZT 100 mg capsules NRTIs (single): Abacavir,

More information

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH

COMMERCIAL APIs. S. No Molecule Name Therapeutic Category USDMF EDMF CEP IH 1 Abacavir Sulphate Antiretroviral - * - 2 Abiraterone Acetate Oncology - - - 3 Albendazole Anti-infective - - - 4 Albuterol Sulphate Respiratory - - 5 Alendronate Sodium Trihydrate Metabolic Disorder

More information

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6

PORTFOLIO Q October 2015 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/6 Abiraterone Tablet 250 mg Q4 2016 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Available Alendronic Acid Tablet 70 mg Available Amikacin Solution for injection 50 mg/ml; 125mg/ml;

More information

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved

Product Name Strength Dosage Form Therapeutic Area Dossier Status. Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Product Name Strength Dosage Form Therapeutic Area Dossier Status Aceclofenac 100mg Film coated Tablets Analgesia-inflammation Approved Alendronate Sodium 10/70mg Tablets Osteoporosis Approved Anastrozole

More information

LIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope

LIST OF PRODUCTS INJECTIONS DRY POWDER INJECTIONS & LIQUID INJECTIONS. Therapeutic Segment. S.No Name Form Pharmacope LIST OF PRODUCTS S.No Name Form Pharmacope ia Strength Therapeutic Segment ECTIONS DRY POWDER ECTIONS & LIQUID ECTIONS 1 a b Arteether 75mg/ml 150 mg/2ml & 225 mg/3ml 2 Amikacin Sulfate IP/ 100/250/500

More information

Approved by TAC Order to be given within 1 month-date

Approved by TAC Order to be given within 1 month-date Approved by TAC Order to be given within 1 month-date 01.10.2018 Sr.No 1 TAB DICLOFENAC 50 MG 2 CEFOTAXIM 500 INJET 3 Inj. Ceftriaxone 500mg Vial 4 Promethazine Inj.25 mg/ml 2 ml Amp 5 Inj. Diclofenac

More information

WHO Model List of Essential Medicines for Children Explanatory Notes

WHO Model List of Essential Medicines for Children Explanatory Notes WHO Model List of Essential Medicines for Children Explanatory Notes This Model List is intended for use for children up to 12 years of age. 16 August 2007 The core list presents a list of minimum medicine

More information

KARNATAKA STATE DRUG LOGISTICS & WAREHOUSING SOCIETY #1, Dr.Siddaiahpuranic Road KHB Colony Magadi Road Bangalore

KARNATAKA STATE DRUG LOGISTICS & WAREHOUSING SOCIETY #1, Dr.Siddaiahpuranic Road KHB Colony Magadi Road Bangalore KARNATAKA STATE DRUG LOGISTICS & WAREHOUSING SOCIETY #1, Dr.Siddaiahpuranic Road KHB Colony Magadi Road Bangalore - 560079 KARNATAKA LIST OF ESSENTIAL MEDICINES, SURGICALS AND MISCELLANEOUS ITEMS 2015-16

More information

Syria Essential Drugs List (EDL) Priority 2014

Syria Essential Drugs List (EDL) Priority 2014 Syria Essential Drugs List (EDL) Priority 2014 1. ANAESTHETICS Quantities halothane Inhalation. 10.000 isoflurane Inhalation. 30.000 sevoflurane bottle (quick fill bottle adapter ) Inhalation. 10.000 nitrous

More information

LIST OF ESSENTIAL MEDICINES OF RA

LIST OF ESSENTIAL MEDICINES OF RA a/ Core List LIST OF ESSENTIAL MEDICINES OF RA 1. Anaesthetics 1.1. General anaesthetics and oxygen Nitrous oxide Inhalation Thiopental Powder for injection: 0.5 g, 1.0 g, (sodium salt) Oxygen Inhalation

More information

LIST OF ESSENTIAL MEDICINES OF RA

LIST OF ESSENTIAL MEDICINES OF RA 1. ANAESTHETICS 1) General anaesthetics and oxygen Inhalational medicines Nitrous Oxide Oxygen Halothane Isoflurane Injectable medicines Ketamine Propofol Thiopental Fentanyl 2) Local anaesthetics Bupivacaine

More information

PRODUCT LIST GENERAL - TABLETS

PRODUCT LIST GENERAL - TABLETS SR. NO. PRODUCT LIST GENERAL - TABLETS 1 Ciprofloxacin Tablets IP 500 mg 2 Ciprofloxacin And Tinidazole Tablets 3 Cefpodoxime Proxetil Tablets IP 4 Cefixime Dispersible Tablets 200 mg 5 Cefixime Dispersible

More information

Administration and Supply of Emergency Medicines

Administration and Supply of Emergency Medicines APPENDIX WHO CAN GIVE WHAT? Administration and Supply of Emergency Clinician Authorisation Key to Exemptions from legislation: NPP Non Parenteral POM. Can be given according to a protocol. 7 HMR 0, Schedule

More information

Product Dose Form Strength RH DH HC HP

Product Dose Form Strength RH DH HC HP GUYANA EDL 2009-2010 Product Dose Form Strength RH DH HC HP 1 1.01 1.01.01 1.01.02 1.02 1.03 Anaesthetics General Anaesthetics and oxygen Intravenous Ketamine Injection 50mg/ml Thiopentone Sodium 0.5g

More information

Kern Pharma Portfolio 2014

Kern Pharma Portfolio 2014 Kern Pharma Portfolio 2014 DOSSIERS DEVELOPED DURING 2013-2014 ARIPIPRAZOL (ODT) 10mg, 15mg tablets CHONDROITIN SULPHATE 400mg capsules ( well established use ) DEXKETOPROFEN TROMETAMOL 25mg, tablets DULOXETIN

More information

TABLETS & CAPSULES. 8 Artemether + Lumafentarine Tablet (24 Tablet ) and Candesartan Tablet 8mg,16mg and 32 mg

TABLETS & CAPSULES. 8 Artemether + Lumafentarine Tablet (24 Tablet ) and Candesartan Tablet 8mg,16mg and 32 mg TABLETS & CAPSULES Sr. No. Name of the product Strength 1 6-Mercaptopurine Tablets 50mg 2 Acetazolamide Tablet 250 mg 3 Al2O3 + Mg(OH)2 chewable Tablet 200 mg/200 mg 4 Allopurinol Tablet 100 mg 5 Ambroxol

More information

Drug Name. Code Artesunate Injection 60 mg/ml Chloroquine Phosphate Injection 40 mg/ml

Drug Name. Code Artesunate Injection 60 mg/ml Chloroquine Phosphate Injection 40 mg/ml Sr.No New Drug Code Drug Name 1 26.1.275.2 Artesunate Injection 60 mg/ml 2 26.1.277.2 Chloroquine Phosphate Injection 40 mg/ml 3 26.1.277.4 Chloroquine Phosphate Tablet 250 mg, equivalent to 155 mg chloroquine

More information

Sl.No Drug code Drug Name Dosage Form Strength Unit Pack Lignocaine Hydrochloride Injection 4% w/v 1x30ml Vial 10.5

Sl.No Drug code Drug Name Dosage Form Strength Unit Pack Lignocaine Hydrochloride Injection 4% w/v 1x30ml Vial 10.5 KARNATAKA STATE DRUG LOGISTICS & WAREHOUSING SOCIETY #1, Dr.Siddaiahpuranic Road KHB Colony Magadi Road Bangalore - 560079 KARNATAKA LIST OF ESSENTIAL MEDICINES, SURGICALS AND MISCELLANEOUS ITEMS 2016-17

More information

PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5

PORTFOLIO Q June 2014 Availability of products is subject to patent restrictions in countries where applicable patents are in effect 1/5 Abiraterone Tablet 250 mg Q4 2015 Acetylsalicylic Acid Tablet GR 100 mg Available Aciclovir Cream 5% - 2 Grs Q4 2014 Alendronic Acid Tablet 70 mg Available Amisulpride Tablet 50 ; 100 ; 200 ; 400 mg Available

More information

Priority essential medicines: identifying products. Dr Suzanne Hill September 2010

Priority essential medicines: identifying products. Dr Suzanne Hill September 2010 Priority essential medicines: identifying products Dr Suzanne Hill September 2010 The problem looks like this Robertson, Forte, Trapsida & Hill. Bull WHO 2009 Robertson, Forte, Trapsida & Hill. Bull WHO

More information

Release of the 2017/18 Invitation to Tender

Release of the 2017/18 Invitation to Tender 2 November 2017 Release of the 2017/18 Invitation to Tender The 2017/18 Invitation to Tender (2017/18 ITT) has been distributed today. If you have already registered your e-mail address with PHARMAC s

More information

Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A

Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A Supportive Care in Cancer Use of Prophylactic Growth Factors and Antimicrobials in Elderly Patients with Cancer: A Systematic Review of the Medicare Database Romina Sosa, Shuling Li, Julia T. Molony, Jiannong

More information

CEFACLOR Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins

CEFACLOR Non Formulary 5.1 Antibacterial drugs->5.1.2 Cephalosporins, carbapenems, and other beta-lactams-> Cephalosporins Report generated from BNF - Local Information provided by FormularyComplete (www.pharmpress.com). Accessed 31 07 2017 Title Formulary Status Section Amikacin Non Formulary 5.1 Antibacterial drugs->5.1.4

More information

2015 Edition. Trust Medicines Formulary

2015 Edition. Trust Medicines Formulary 2015 Edition Trust Medicines Formulary Introduction Trust Medicines Formulary This formulary summarises all medicines used within the Trust, the Trust defines medicines as any substance, controlled or

More information

1 ml) (100 x. 10 ml)

1 ml) (100 x. 10 ml) SCHEDULE COPY NICIPAL CORPORATION OF GREATER MUM NTRAL PURCHASE AUTHORITY DEPARTME SCHEDULE I OF 2010-2011 INJECTIONS & SERA VACCINES CONTRACT PERIOD : 1-1-2010 To 31-12-2011 Item Description Quantity

More information

List of Liquid Oral/Dry Syrup Section

List of Liquid Oral/Dry Syrup Section List of Liquid Oral/Dry Syrup Section Antibiotics & Anti-Infective S.No Product Name Composition 1. Amoxicillin Oral Suspension BP ( /5ml ) ( Zeemox Syrup ) 2. Amoxicillin Oral Suspension BP (/5ml ) 3.

More information

Elizabeta Zisovska, Skopje, Republic of Macedonia

Elizabeta Zisovska, Skopje, Republic of Macedonia Elizabeta Zisovska, Skopje, Republic of Macedonia The comments are extracted and supported by the Drug register (for registered drugs in Republic of Macedonia) issued by the ministry of health, Republic

More information

An introduction to the Essential Medicines concept: balancing innovation with public health priorities

An introduction to the Essential Medicines concept: balancing innovation with public health priorities An introduction to the Essential Medicines concept: balancing innovation with public health priorities WHO HQ, Geneva 11 October 2017 Nicola Magrini Secretary, WHO Expert Committee on the Selection and

More information

ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY

ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY ELECTRONIC HEALTH RECORD (EHR) ENHANCEMENTS FOR MARCH 15, 2016 SUMMARY Problem Opening PACS Images on ipads or ibooks has Been Fixed Changes have been made in PROD to enable user credentials to be passed

More information

Hospital Pharmaceuticals Review PTAC, Hospital Pharmaceuticals Subcommittee & Anti-Infective Subcommittee minutes for web publishing

Hospital Pharmaceuticals Review PTAC, Hospital Pharmaceuticals Subcommittee & Anti-Infective Subcommittee minutes for web publishing Hospital Pharmaceuticals Review PTAC, Hospital Pharmaceuticals Subcommittee & Anti-Infective Subcommittee minutes for web publishing Infections therapeutic group PTAC and Subcommittee of PTAC minutes are

More information

Product List Finished Dosage Forms (FDF) B2B Business

Product List Finished Dosage Forms (FDF) B2B Business Product List 2017 Finished Dosage Forms (FDF) B2B Business Anaesthetics Dermatology Lidocaine Lidocaine and Prilocaine Dexmedetomidine Hydrochloride Anti-Infectives Amoxicillin Trihydrate and Potassium

More information

Drug Schedule For RC 145 ITEM S.No. NO. ITEM NAME and DESCRIPTION Unit Turnover (Rs.) EMD (Rs.)

Drug Schedule For RC 145 ITEM S.No. NO. ITEM NAME and DESCRIPTION Unit Turnover (Rs.) EMD (Rs.) HORMONES S.No. NO. NAME and DESCRIPTION Unit Turnover EMD NORETHISTERONE - Each tab to contain: 1 128 Norethisterone 5mg. 1 tab 5100000 50000 100000 DANAZOL TAB/CAP - Each tab/cap to contain: 2 132a Danazol

More information

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364

J1556 INJECTION, IMMUNE GLOBULIN (BIVIGAM) 500 MG $ J1559 INJECTION, IMMUNE GLOBULIN (HIZENTRA) 100 MG $14.364 G0333 INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.470 J0285 INJECTION, AMPHOTERICIN B 50 MG $10.280 J0287 INJECTION, AMPHOTERICIN B LIPID COMPLEX 10 MG $21.850 J0288

More information

Clinical Manual. Part 4 Standard Drug List. Version 8.1 July [Type text]

Clinical Manual. Part 4 Standard Drug List. Version 8.1 July [Type text] Clinical Manual Part 4 Standard Drug List Version 8.1 July 2018 [Type text] Royal Flying Doctor Service Western Operations 3 Eagle Drive, Jandakot Airport, Western Australia 6164 T 61-8-9417 6300 F 61-8-9417

More information

WHO Model List of Essential Medicines

WHO Model List of Essential Medicines of Essential Medicines 15 th list, March 2007 Status of this document This is a reprint of the text on the WHO Medicines web site http://www.who.int/medicines/publications/essentialmedicines/en/index.html

More information

WHO Model List of Essential Medicines

WHO Model List of Essential Medicines WHO Model List of Essential Medicines 20th List (March 2017) (Amended August 2017) Status of this document This is a reprint of the text on the WHO Medicines website http://www.who.int/medicines/publications/essentialmedicines/en/

More information

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018

DME MAC Jurisdiction C Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2018 through 03/31/2018 G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.068 J0285 INJECTION, AMPHOTERICIN B 50 MG $32.987 J0287 INJECTION,

More information

10 Musculoskeletal and Joint Diseases

10 Musculoskeletal and Joint Diseases 10 Musculoskeletal and Joint Diseases To be used in conjunction with NICE guidance, The British National Formulary for adults and/or children and British Society of Rheumatology guidelines and guidance

More information

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019

DME MAC Jurisdiction B Drug Fees, Pharmacy Dispensing Fees and Pharmacy Supply Fees Effective 01/01/2019 through 03/31/2019 G0333 PHARMACY DISPENSING FEE FOR INHALATION DRUG(S); INITIAL 30-DAY SUPPLY AS A BENEFICIARY $57.000 J0133 INJECTION, ACYCLOVIR 5 MG $0.048 J0285 INJECTION, AMPHOTERICIN B 50 MG $31.668 J0287 INJECTION,

More information

PROGRAM General Information

PROGRAM General Information Association for Quality Assessment in TDM and Clinical Toxicology Section of the Dutch Foundation for Quality Assessment in Medical Laboratories PROGRAM 2016 General Information P.O. Box 43100, 2504 AC

More information

NHS Fife Antibiotic Guidance for the Treatment of Community Managed Infections

NHS Fife Antibiotic Guidance for the Treatment of Community Managed Infections 1 5. Infections Also see Primary Care and Hospital Antibiotic Guidance NHS Fife Antibiotic Guidance for the Treatment of Community Managed Infections Management of Serious Infections in Paediatrics. Guidance

More information

1 Anaesthetics 1.1 General Anaesthetics and Oxygen

1 Anaesthetics 1.1 General Anaesthetics and Oxygen 1 Anaesthetics 1.1 General Anaesthetics and Oxygen Halothane liq 250mls 3 Ketamine amp 50mg 3 Medical Oxygen inh medicinal gas 3 Nitrous Oxide inh medicinal gas 3 Propofol amp 10mg 3 Thiopentone sodium

More information

Active Pharmaceutical Ingredient (API) List List Updated March 1st, 2019

Active Pharmaceutical Ingredient (API) List List Updated March 1st, 2019 5-Fluorouracil 5-FU, Fluorouracil Stability Indicating HPLC-UV USP 7-keto DHEA Stability Indicating HPLC-UV Medisca Tier 1 Acetaminophen Stability Indicating HPLC-UV USP Adenosine Alprostadil PGE-1, Prostaglandin

More information

Thank you for your request for information that has been processed under reference number

Thank you for your request for information that has been processed under reference number Corporate Development Contact us: dhft.foi@nhs.net Royal Derby Hospital Uttoxeter Road Derby DE22 3NE Tel: 01332 265500 Minicom: 01332 785566 www.derbyhospitals@nhs.uk Follow us on Twitter @DerbyHospitals

More information

WHO Model List of Essential Medicines for Children

WHO Model List of Essential Medicines for Children WHO Model List of Essential Medicines for Children 6th List (March 2017) (Amended August 2017) Status of this document This is a reprint of the text on the WHO Medicines website http://www.who.int/medicines/publications/essentialmedicines/en/

More information

Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj.

Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. Dry injection list 1-Ceftriaxone 1000 mg & Sulbactam 500 mg Inj. 2-Ceftriaxone 500 mg & Sulbactam 250 mg Inj. 3-Ceftriaxone 250mg & Sulbactam 125mg Inj. 4-Ceftriaxone 125mg & Sulbactam 62.5mg Inj. 5-Rabeprazole

More information

Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites.

Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites. WARDS/DEPARTMENTS By: 0 01/09/019 1 of 3 Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites. Scope: All Black

More information

EDL Details for (Name of the Medical College and Hospital : )

EDL Details for (Name of the Medical College and Hospital : ) EDL Details for (Name of the Medical College and Hospital : ) Financial Year: 2013-2014 Sl.no Drug Code Drug Name Strength Packing Unit Quantity 1 D0003 Aceclofenac 100 Mg 2 D0006 Acetyl Salicylic Acid

More information

Elite Pharma (Pvt.) Ltd., Lahore Pakistan (Injectables)

Elite Pharma (Pvt.) Ltd., Lahore Pakistan (Injectables) 1 022237 Aqua Elite Water for Injection 5ml 100 x 5ml 2 022238 Neuro -S (Each 3ml contains: B1 + B6 + B12) Vitamins 25 x 3ml 5 x 3ml 100 x 3ml 4 024864 Elusen (Frusemide --- 20mg / 2ml] Diuretic 50 x 2ml

More information

Both adult and pediatric* 24 (46% of 52 members) Region: New England 51 (48% of 107 members) 45 (52% of 87 members) 29 (47% of 62 members)

Both adult and pediatric* 24 (46% of 52 members) Region: New England 51 (48% of 107 members) 45 (52% of 87 members) 29 (47% of 62 members) Infectious Diseases Society of America Emerging Infections Network Report for Query: Antimicrobial Drug Shortages 2016 Overall response rate: 701/1,597 (44%) physicians responded from 3/22/16 to 4/13/16.

More information

Essential Medicines 15th edition (March 2007) WHO Model List (revised March 2007)

Essential Medicines 15th edition (March 2007) WHO Model List (revised March 2007) Explanatory Notes The core list presents a list of minimum medicine needs for a basic health care system, listing the most efficacious, safe and cost effective medicines for priority conditions. Priority

More information

BAPTIST MEDICAL CENTRE. MEDICINES LIST Last updated August ANALGESICS Acetylsalicylic Acid (Aspirin) 300mg MDD 4g/day, C/D Diclofenac 100mg caps

BAPTIST MEDICAL CENTRE. MEDICINES LIST Last updated August ANALGESICS Acetylsalicylic Acid (Aspirin) 300mg MDD 4g/day, C/D Diclofenac 100mg caps BAPTIST MEDICAL CENTRE MEDICINES LIST Last updated August 2018 ANALGESICS Acetylsalicylic Acid (Aspirin) 300mg MDD 4g/day, C/D Diclofenac 50mg tabs TID Diclofenac 100mg caps BID, MDD 200mg/day Diclofenac

More information

Old Code Group Category Drug Name Full Drug Name Specification Suggested Specification. Oxygen Oxygen Inhalation (medicinal gas)

Old Code Group Category Drug Name Full Drug Name Specification Suggested Specification. Oxygen Oxygen Inhalation (medicinal gas) ESSENTIAL DRUG LIST 2015 S.No Compone Old Code Group Category Drug Name Full Drug Name Suggested 1 1.1.1.1 1.1.4 ANAESTHETICS General Anaesthetics and Oxygen Oxygen Oxygen Inhalation (medicinal gas) 1.

More information

Drug Typical Dose CrCl (ml/min) Dose adjustment for renal insufficiency Acyclovir PO (HSV) 400 mg TID >10 <10 or HD PD

Drug Typical Dose CrCl (ml/min) Dose adjustment for renal insufficiency Acyclovir PO (HSV) 400 mg TID >10 <10 or HD PD Antimicrobial Dosing in Renal Insufficiency (Adults) ASP Handbook * In patients on hemodialysis (), give antimicrobial immediately after dialysis on dialysis days. = Intermittent hemodialysis = Peritoneal

More information

Medicines recommended to prevent and manage the priority diseases at the community and health facility level

Medicines recommended to prevent and manage the priority diseases at the community and health facility level s recommended to prevent and manage the priority diseases at the community and health facility level Shamim Qazi Department of Child and Adolescent Health and Development Global Causes of Child Deaths

More information

ESSENTIAL DRUG LIST 2015, Haryana

ESSENTIAL DRUG LIST 2015, Haryana 1 1.1.1.1 ANAESTHETICS General Anaesthetics and ESSENTIAL DRUG LIST 2015, Haryana Inhalation (medicinal gas) 1. Medical IP Cylinder ( 93% "For Medicinal Use ") 2. Liquified ( 93% "For Medicinal Use") 2

More information

ESSENTIAL MEDICINES LIST OF THERAPEUTIC CATEGORIES

ESSENTIAL MEDICINES LIST OF THERAPEUTIC CATEGORIES GAMBIA ESSENTIAL MEDICINES LIST ESSENTIAL MEDICINES LIST OF THERAPEUTIC CATEGORIES 1 ANEASTHETICS 1.1 GENERAL ANAESTHETICS Halothane Inhalation liquid, lsoflurane 5% Ketamine 50mg/ml injection Oxygen (medical

More information

IMDG CODE Poison Treatment Chest

IMDG CODE Poison Treatment Chest 2018 IMDG CODE Poison Treatment Chest This document contains the complete list of medicines and medical supplies for the vessels poison treatment chest and is based on the IMDG code international maritime

More information

Chapter 4 ~ Central nervous system

Chapter 4 ~ Central nervous system Chapter 4 ~ Central Nervous System: General Section 1 of 6 Chapter 4 ~ Central nervous system 4.1 Hypnotics and anxiolytics 4.1.1 Hypnotics CHLORAL HYDRATE CLOMETHIAZOLE NITRAZEPAM TEMAZEPAM TRICLOFOS

More information

Inventory of paediatric therapeutic needs

Inventory of paediatric therapeutic needs 12 December 2012 EMA/PDCO/287222/2012 Human Medicines Development and Evaluation Infectious diseases Agreed by PDCO November 2012 Adopted by PDCO for release for consultation 7 December 2012 Start of public

More information

Report generated from BNF provided by FormularyComplete ( Accessed TA Number. Title Formulary Status Section

Report generated from BNF provided by FormularyComplete (  Accessed TA Number. Title Formulary Status Section Report generated from BNF provided by FormularyComplete (www.pharmpress.com). Accessed 16 02 2017 Title Formulary Status Section TA Number TA Link Annotation ACICLOVIR Aciclovir 5.3 Antiviral drugs->5.3.2

More information

WHO Model List of Essential Medicines for Children

WHO Model List of Essential Medicines for Children WHO Model List of Essential Medicines for Children 2nd List, March 2009 Status of this document This is a reprint of the text on the WHO Medicines web site http://www.who.int/medicines/publications/essentialmedicines/en/index.html

More information

Monographs on ARV and hepatitis medicines in The International Pharmacopoeia

Monographs on ARV and hepatitis medicines in The International Pharmacopoeia Monographs on ARV and hepatitis medicines in The International Pharmacopoeia Technologies, Standards and Norms 1 The International Pharmacopoeia contains analytical methods and specifications for active

More information

Guidelines for the Use of Anti-Emetics with Chemotherapy

Guidelines for the Use of Anti-Emetics with Chemotherapy Guidelines for the Use of Anti-Emetics with The purpose of this document is to provide guidance on the rational use of anti-emetics for prevention and treatment of chemotherapy-induced nausea and vomiting

More information

West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting

West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting Definitions Acute nausea and vomiting Delayed nausea and vomiting Anticipatory nausea and vomiting Initial

More information

July Formulary Policy

July Formulary Policy Formulary Policy July 2017 Responsible Committee: Quality Committee Date Effective: July 2017 Author: Rahinatu Amadu Supersedes: July 2016 Next Review Due: July 2018 Formulary Policy 2016-2018 1. INTRODUCTION

More information

EXPRESSION OF INTEREST SUPPLY OF MEDICINES FOR THE GOVERNMENT OF FIJI FREE MEDICINE INITIATIVE

EXPRESSION OF INTEREST SUPPLY OF MEDICINES FOR THE GOVERNMENT OF FIJI FREE MEDICINE INITIATIVE EXPRESSION OF INTEREST SUPPLY OF MEDICINES FOR THE GOVERNMENT OF FIJI FREE MEDICINE INITIATIVE The Fijian Government invites expressions of interest from reputable Manufacturers and Suppliers for the supply

More information

Professionalism & Service with Great Prices

Professionalism & Service with Great Prices Acyclovir Capsules 200mg Viruses 30 90 Albuterol Syrup 2mg/5ml Asthma 120 360 Albuterol Sulfate Solution 0.05% * Asthma ----- ----- 20 60 Albuterol Sulfate Solution 0.083% Asthma ----- ----- 75 225 Alendronate

More information